Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.38 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.36 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | USP2 | O75604 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5988356 | 0.83 | APOBEC3G (0.40) | APOBEC3GPDCD1CD274LTB4R2ALDH1A1 | |
| SCHEMBL308283 | 0.83 | APOBEC3G (0.46) | APOBEC3GPDCD1CD274ALDH1A1HPGD | |
| SCHEMBL2791608 | 0.82 | PDK2 (0.38) | PDCD1CD274LTB4R2PDK2 | |
| SCHEMBL22639370 | 0.81 | CYP2C19 (0.39) | APOBEC3GPDCD1CD274ALDH1A1MAPT | |
| SCHEMBL11388986 | 0.76 | GABRA1 (0.38) | ALDH1A1KDM4EMAPTMEN1KMT2A | |
| SCHEMBL3144684 | 0.74 | POLB (0.41) | LTB4R2ALDH1A1KDM4EMAPTUSP2 | |
| SCHEMBL13809371 | 0.74 | POLB (0.33) | ALDH1A1KDM4EMAPTHPGDHSD17B10 | |
| SCHEMBL13385638 | 0.74 | CYP1A2 (0.41) | MEN1KMT2APOLBCYP1A2CYP2D6 | |
| SCHEMBL15102307 | 0.73 | TSHR (0.41) | APOBEC3GLTB4R2CYP4F2CYP4A11MEN1 | |
| SCHEMBL22639357 | 0.73 | S1PR1 (0.42) | APOBEC3GPDCD1CD274ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180004102-A1 | METHOD FOR MANUFACTURING FLUORINATED STRUCUTURED ORGANIC PHOTORECEPTOR LAYERS | XEROX CORPORATION | 2018-01-04 | — | — | US | claimed |
| US-20180004103-A1 | FLUORINATED STRUCUTURED ORGANIC FILM LAYERS | XEROX CORPORATION | 2018-01-04 | — | — | US | claimed |
| US-8591997-B2 | Process for preparing structured organic films (SOFS) via a pre-SOF | XEROX CORPORATION (US) | 2013-11-26 | — | — | US | claimed |
| US-20240239967-A1 | VISCOUS BIO-DERIVED SOLVENTS FOR STRUCTURED ORGANIC FILM (SOF) COMPOSITIONS | XEROX CORPORATION (US) | 2024-07-18 | — | — | US | disclosed |
| US-20240174808-A1 | STRUCTURED ORGANIC FILMS CONTAINING N-CYCLIC QUATERNARY AMMONIUM HAVING CATIONIC CHARGE FUNCTIONALITY AND METHODS THEREOF | XEROX CORPORATION (US) | 2024-05-30 | — | — | US | disclosed |
| US-20240116858-A1 | GRADIENT MEMBRANES FORMED FROM FREE STANDING STRUCTURED ORGANIC FILMS AND METHODS THEREOF | XEROX CORPORATION (US) | 2024-04-11 | — | — | US | disclosed |
| US-20240115974-A1 | ANION EXCHANGE MEMBRANES FROM STRUCTURED ORGANIC FILMS AND METHODS THEREOF | XEROX CORPORATION (US) | 2024-04-11 | — | — | US | disclosed |
| US-20240115975-A1 | CATION EXCHANGE MEMBRANES FROM STRUCTURED ORGANIC FILMS AND METHODS THEREOF | XEROX CORPORATION (US) | 2024-04-11 | — | — | US | disclosed |
| EP-4350821-A1 | ANION EXCHANGE MEMBRANES FROM STRUCTURED ORGANIC FILMS AND METHODS THEREOF | Xerox Corporation (US) | 2024-04-10 | — | — | EP | disclosed |
| US-20240110008-A1 | STRUCTURED ORGANIC FILMS CONTAINING IMIDAZOLIUM HAVING CATIONIC CHARGE FUNCTIONALITY AND METHODS THEREOF | XEROX CORPORATION (US) | 2024-04-04 | — | — | US | disclosed |
| EP-4338823-A1 | GRADIENT MEMBRANES FORMED FROM FREE STANDING STRUCTURED ORGANIC FILMS AND METHODS THEREOF | Xerox Corporation (US) | 2024-03-20 | — | — | EP | disclosed |
| WO-2010102038-A1 | ELECTRONIC DEVICES COMPRISING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-10 | — | — | WO | disclosed |
| WO-2010102018-A1 | MIXED SOLVENT PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-10 | — | — | WO | disclosed |
| WO-2010102025-A1 | STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-10 | — | — | WO | disclosed |
| US-20100227157-A1 | COMPOSITE STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100228025-A1 | STRUCTURED ORGANIC FILMS HAVING AN ADDED FUNCTIONALITY | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100227998-A1 | STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100227081-A1 | MIXED SOLVENT PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100224867-A1 | ELECTRONIC DEVICES COMPRISING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100227071-A1 | PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS (SOFS) VIA A PRE-SOF | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100224867-A1 | ELECTRONIC DEVICES COMPRISING STRUCTURED ORGANIC FILMS | EPCAM, EPHA6, EED | APOBEC3G 1435/4885PDCD1 1330/4885CD274 869/4885 |
| US-20100228025-A1 | STRUCTURED ORGANIC FILMS HAVING AN ADDED FUNCTIONALITY | VIM, PUF60, EPCAM | APOBEC3G 1129/4885PDCD1 3366/4885CD274 2680/4885 |
| US-20240174808-A1 | STRUCTURED ORGANIC FILMS CONTAINING N-CYCLIC QUATERNARY AMMONIUM HAVING CATIONIC CHARGE FUNCTIONALITY AND METHODS THEREOF | NONO, PAM, AQP4 | APOBEC3G 1113/4885PDCD1 4167/4885CD274 4590/4885 |
| US-20100227998-A1 | STRUCTURED ORGANIC FILMS | VIM, PUF60, EPCAM | APOBEC3G 1247/4885PDCD1 2539/4885CD274 1962/4885 |
| US-20240116858-A1 | GRADIENT MEMBRANES FORMED FROM FREE STANDING STRUCTURED ORGANIC FILMS AND METHODS THEREOF | EPCAM, OSTC, DSP | APOBEC3G 2994/4885PDCD1 3626/4885CD274 3221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.